Derek Yuan

Derek Yuan, Ph.D. is a managing director at LYFE Capital and has been working there since the start of the investment team in 2018. He has been involved in multiple investments, including Pliant Therapeutics, Tempest Therapeutics, Cytek Biosciences, Immuneering, Kyverna, ImmuneOnco, and Aspen Neurosciences. Prior to LYFE Capital, Derek worked at Biotech Equity Research at Credit Suisse. He received his Ph.D. degree in chemical biology from the Rockefeller University and his B.S. in chemistry and biology from Tsinghua University.